WHO ICTRP trial
To investigate calcium metabolism as a therapeutic target in multiple sclerosis…
DRKS00024950 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00024950 |
|---|---|
| Public title | To investigate calcium metabolism as a therapeutic target in multiple sclerosis (MS) |
| Scientific title | To investigate calcium metabolism as a therapeutic target in multiple sclerosis (MS) |
| Primary sponsor | Universitätsmedizin Göttingen |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | G35;Multiple sclerosis |
| Interventions | Group 1: To investigate the role of calcium on the activation and differentiation of peripheral blood mononuclear cells (T cells, B cells and monocytes) in patients with hypertension, which received a calcium antagonist therapy, as compared… |
| Registration date | Jan 4, 2021 |
| Target size | 90 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: